BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1151 related articles for article (PubMed ID: 19770381)

  • 1. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
    Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
    J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
    Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
    Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.
    Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR
    BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
    Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
    Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
    Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
    Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
    van der Veer A; Zaliova M; Mottadelli F; De Lorenzo P; Te Kronnie G; Harrison CJ; Cavé H; Trka J; Saha V; Schrappe M; Pieters R; Biondi A; Valsecchi MG; Stanulla M; den Boer ML; Cazzaniga G
    Blood; 2014 Mar; 123(11):1691-8. PubMed ID: 24366361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of IKZF1 gene copy number abnormalities in BCR/ABL-negative B-lineage acute lymphoblastic leukemia in children].
    Zou Y; Liu XM; Zhang L; Chen YM; Guo Y; Chen XJ; Yang WY; Wang SC; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1154-9. PubMed ID: 26575870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
    Yanada M; Sugiura I; Takeuchi J; Akiyama H; Maruta A; Ueda Y; Usui N; Yagasaki F; Yujiri T; Takeuchi M; Nishii K; Kimura Y; Miyawaki S; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
    Br J Haematol; 2008 Nov; 143(4):503-10. PubMed ID: 18986386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.
    Yang YL; Hung CC; Chen JS; Lin KH; Jou ST; Hsiao CC; Sheen JM; Cheng CN; Wu KH; Lin SR; Yu SL; Chen HY; Lu MY; Wang SC; Chang HH; Lin SW; Su YN; Lin DT
    Cancer Sci; 2011 Oct; 102(10):1874-81. PubMed ID: 21740479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
    Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G
    Haematologica; 2008 Dec; 93(12):1814-21. PubMed ID: 18838475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
    Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
    Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
    Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
    Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Kobayashi T; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Emi N; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
    J Clin Oncol; 2006 Jan; 24(3):460-6. PubMed ID: 16344315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.